The 10-panel is simply a broader version of the 5-panel, covering more categories of prescription and recreational drugs
Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q22024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, and tirzepatide
BBB dysregulation precedes A and tau protein deposition, cognitive decline, and structural changes in brain tissue (Iturria-Medina et al., 2016)
For example, the Medline search included: exp Fibromyalgia/or fibromyalgia.mp
Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome